Globe Life (NYSE:GL) Stock Price Down 6.3% on Analyst Downgrade

Key Points

• Globe Life shares fell 6.3% after TD Cowen cut its price target from $225 to $215, although it maintained a buy rating. The stock traded near $157.72, with volume about 49% below its average.
• Analyst sentiment remains positive overall, with a consensus “Moderate Buy” rating and an average target price of $182.60; other firms recently adjusted targets while retaining mostly buy or overweight ratings.
• Globe Life reported 5.5% year-over-year revenue growth to $1.60 billion, but quarterly EPS of $4.84 missed estimates amid weaker underwriting income and higher expenses. Insiders sold roughly $25.8 million of shares over the past 90 days, while the company maintains a $2.5 billion share-repurchase authorization.

Globe Life Inc. (NYSE:GL - Get Free Report)'s share price fell 6.3% on Friday after TD Cowen lowered their price target on the stock from $225.00 to $215.00. TD Cowen currently has a buy rating on the stock. Globe Life traded as low as $159.45 and last traded at $157.7170. 274,396 shares traded hands during mid-day trading, a decline of 49% from the average daily volume of 540,886 shares. The stock had previously closed at $168.41.

A number of other research firms also recently issued reports on GL. Keefe, Bruyette & Woods dropped their target price on shares of Globe Life from $192.00 to $190.00 and set an "outperform" rating on the stock in a research report on Friday, July 24th. Morgan Stanley cut their price target on shares of Globe Life from $208.00 to $197.00 and set an "overweight" rating for the company in a report on Monday, October 5th. Weiss Ratings upgraded shares of Globe Life from a "buy (b-)" rating to a "buy (b)" rating in a report on Wednesday. JPMorgan Chase & Co. upped their target price on Globe Life from $193.00 to $195.00 and gave the company an "overweight" rating in a report on Thursday, October 15th. Finally, Jefferies Financial Group lifted their target price on shares of Globe Life from $147.00 to $166.00 and gave the company a "hold" rating in a report on Friday, July 10th. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and three have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $182.60.

Insider Buying and Selling at Globe Life

In other news, EVP Robert Hensley sold 10,000 shares of Globe Life stock in a transaction on Tuesday, September 22nd. The stock was sold at an average price of $170.07, for a total value of $1,700,700.00. Following the transaction, the executive vice president directly owned 12,384 shares in the company, valued at approximately $2,106,146.88. This trade represents a 44.67% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CFO Thomas Kalmbach sold 21,000 shares of Globe Life stock in a transaction dated Thursday, July 30th. The stock was sold at an average price of $180.06, for a total value of $3,781,260.00. Following the sale, the chief financial officer directly owned 50,568 shares of the company's stock, valued at approximately $9,105,274.08. This represents a 29.34% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 143,650 shares of company stock valued at $25,793,717 in the last ninety days. 2.11% of the stock is owned by insiders.

Trending Headlines about Globe Life

Here are the key news stories impacting Globe Life this week:

• Positive Sentiment: Globe Life reported third-quarter revenue of approximately $1.60 billion, above the $1.56 billion analyst consensus, with revenue up 5.5% year over year. Operating EPS increased to $4.84 from $4.81 a year earlier. Globe Life third-quarter 2026 results
• Positive Sentiment: Management is targeting $850 million to $950 million in parent excess cash flow for 2027, which could support capital returns, debt reduction or other shareholder-friendly actions. The company projects 2027 EPS of $16.10 to $17.10, a range that includes the $16.51 consensus estimate. Globe Life 2027 outlook
• Neutral Sentiment: The company’s 2027 EPS guidance of $16.10 to $17.10 implies continued earnings growth, but the broad range suggests uncertainty around operating performance and future underwriting results.
• Negative Sentiment: Third-quarter operating EPS of $4.84 missed estimates ranging from $4.87 to $4.90. Weaker underwriting income and higher expenses offset gains from increased premiums and investment income. Globe Life Q3 earnings miss
• Negative Sentiment: Globe Life cut its FY 2026 EPS outlook to $15.35-$15.65, below the $15.72 consensus estimate. Reports also cited losses at Evry Health as a factor pressuring the full-year guidance. Evry Health losses and Globe Life guidance
• Negative Sentiment: The quarter included a reported underwriting loss of about $6.4 million, raising investor concerns about claims trends, expense control and the company’s ability to convert premium growth into profits. Globe Life underwriting loss analysis

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the business. BlackRock Inc. acquired a new position in Globe Life in the 2nd quarter valued at $987,901,000. State Street Corp increased its position in Globe Life by 2.1% in the second quarter. State Street Corp now owns 3,735,409 shares of the company's stock worth $667,443,000 after buying an additional 76,745 shares during the period. Dimensional Fund Advisors LP increased its position in Globe Life by 10.2% in the 1st quarter. Dimensional Fund Advisors LP now owns 2,353,192 shares of the company's stock valued at $327,479,000 after acquiring an additional 217,331 shares during the period. Pzena Investment Management LLC bought a new stake in shares of Globe Life in the 2nd quarter worth $242,256,000. Finally, Swedbank AB boosted its stake in shares of Globe Life by 15.3% during the 1st quarter. Swedbank AB now owns 1,109,200 shares of the company's stock worth $154,367,000 after acquiring an additional 147,200 shares in the last quarter. Hedge funds and other institutional investors own 81.61% of the company's stock.

Globe Life Stock Performance

The firm's 50-day simple moving average is $170.48 and its two-hundred day simple moving average is $167.25. The stock has a market capitalization of $12.11 billion, a PE ratio of 10.47 and a beta of 0.44. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.43.

Globe Life (NYSE:GL - Get Free Report) last posted its earnings results on Wednesday, October 21st. The company reported $4.84 EPS for the quarter, missing the consensus estimate of $4.90 by ($0.06). Globe Life had a return on equity of 19.95% and a net margin of 18.89%. The business had revenue of $1.60 billion for the quarter, compared to analyst estimates of $1.56 billion. During the same period in the previous year, the company earned $4.81 earnings per share. The company's quarterly revenue was up 5.5% compared to the same quarter last year. On average, equities research analysts expect that Globe Life Inc. will post 15.70 earnings per share for the current fiscal year.

Globe Life Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Monday, October 5th will be paid a dividend of $0.33 per share. This represents a $1.32 annualized dividend and a dividend yield of 0.8%. The ex-dividend date of this dividend is Monday, October 5th. Globe Life's dividend payout ratio is 8.76%.

Globe Life declared that its Board of Directors has initiated a share buyback program on Monday, August 10th that authorizes the company to buy back $2.50 billion in outstanding shares. This buyback authorization authorizes the company to reacquire up to 17.7% of its shares through open market purchases. Stock buyback programs are often a sign that the company's management believes its stock is undervalued.

Globe Life Company Profile

Globe Life Inc NYSE: GL is an insurance holding company that provides individual life and supplemental health insurance products through a network of wholly owned subsidiaries. Its offerings are designed primarily for middle-income households and include term and whole life insurance, mortgage protection coverage, accident and supplemental health insurance, Medicare supplement policies, and annuities.

The company markets its products through several distribution channels, including exclusive and independent agency networks, direct-to-consumer sales, and workplace or union-affiliated programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.